Tumor Responsive and Tunable Polymeric Platform for Optimized Delivery of Paclitaxel to Treat Glioblastoma-Reference-Cited by-同舟云学术

Tumor Responsive and Tunable Polymeric Platform for Optimized Delivery of Paclitaxel to Treat Glioblastoma

Published:2020-04-06 Issue:17 Volume:12 Page:19345-19356
ISSN:1944-8244
Container-title:ACS Applied Materials & Interfaces
language:en
Short-container-title:ACS Appl. Mater. Interfaces

Author:

Graham-Gurysh Elizabeth G.¹^ORCID,Moore Kathryn M.²,Schorzman Allison N.³⁴,Lee Taek⁴,Zamboni William C.³⁴⁵,Hingtgen Shawn D.¹,Bachelder Eric M.¹^ORCID,Ainslie Kristy M.¹²³^ORCID

Affiliation:

1. Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, 4211 Marsico Hall, 125 Mason Farm Road, Chapel Hill, North Carolina 27599, United States

2. UNC/NCSU Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States

3. Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States

4. Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States

5. Carolina Center of Cancer Nanotechnology Excellence, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States

Funder

National Cancer Institute

National Institute of Neurological Disorders and Stroke

University of North Carolina at Chapel Hill

Pharmaceutical Research and Manufacturers of America Foundation

Publisher

American Chemical Society (ACS)

Subject

General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/acsami.0c04102